ProPhase Labs, Inc. (PRPH)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:03PM EDT. Market open.
| Previous close | 5.42 |
| Open | 5.47 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 5.12 - 5.62 |
| 52-week range | 4.05 - 9.94 |
| Volume | |
| Avg. volume | 54,516 |
| Market cap | 103.024M |
| Beta (5Y monthly) | -0.27 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 24 May 2022 |
| 1y target est | N/A |
- Zacks
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ProPhase Labs (PRPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
Theravance Bio (TBPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Insider Monkey
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript March 15, 2024 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $-0.27. PRPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Noella Alexander-Young: Hello, and good […]
© 2024 Yahoo. All rights reserved.